Metastatic colon cancer, version 3.2013

Featured updates to the NCCN guidelines

Al B. Benson, Tanios Bekaii-Saab, Emily Chan, Yi Jen Chen, Michael A. Choti, Harry S. Cooper, Paul F. Engstrom, Peter C. Enzinger, Marwan G. Fakih, Moon J. Fenton, Charles S. Fuchs, Jean L. Grem, Steven Hunt, Ahmed Kamel, Lucille A. Leong, Edward Lin, Kilian Salerno May, Mary F. Mulcahy, Kate Murphy, Eric Rohren & 11 others David P. Ryan, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, William Small Jr, Constantinos T. Sofocleous, Alan P. Venook, Christopher G. Willett, Kristina M. Gregory, Deborah A. Freedman-Cass

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, peri-operative treatment, patient surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Colon Cancer Panel meets annually to review comments from reviewers within their institutions and to reevaluate and update their recommendations. In addition, the panel has interim conferences as new data necessitate. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel's discussions surrounding metastatic colorectal cancer for the 2013 update of the guidelines. Importantly, changes were made to the continuum of care for patients with advanced or metastatic disease, including new drugs and an additional line of therapy.

Original languageEnglish (US)
Pages (from-to)141-152
Number of pages12
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume11
Issue number2
StatePublished - Feb 1 2013

Fingerprint

Colonic Neoplasms
Guidelines
Continuity of Patient Care
Primary Care Physicians
Practice Guidelines
Colorectal Neoplasms
Survival Rate
Therapeutics
Pharmaceutical Preparations
Gastroenterologists

ASJC Scopus subject areas

  • Oncology

Cite this

Benson, A. B., Bekaii-Saab, T., Chan, E., Chen, Y. J., Choti, M. A., Cooper, H. S., ... Freedman-Cass, D. A. (2013). Metastatic colon cancer, version 3.2013: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 11(2), 141-152.

Metastatic colon cancer, version 3.2013 : Featured updates to the NCCN guidelines. / Benson, Al B.; Bekaii-Saab, Tanios; Chan, Emily; Chen, Yi Jen; Choti, Michael A.; Cooper, Harry S.; Engstrom, Paul F.; Enzinger, Peter C.; Fakih, Marwan G.; Fenton, Moon J.; Fuchs, Charles S.; Grem, Jean L.; Hunt, Steven; Kamel, Ahmed; Leong, Lucille A.; Lin, Edward; May, Kilian Salerno; Mulcahy, Mary F.; Murphy, Kate; Rohren, Eric; Ryan, David P.; Saltz, Leonard; Sharma, Sunil; Shibata, David; Skibber, John M.; Jr, William Small; Sofocleous, Constantinos T.; Venook, Alan P.; Willett, Christopher G.; Gregory, Kristina M.; Freedman-Cass, Deborah A.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 11, No. 2, 01.02.2013, p. 141-152.

Research output: Contribution to journalArticle

Benson, AB, Bekaii-Saab, T, Chan, E, Chen, YJ, Choti, MA, Cooper, HS, Engstrom, PF, Enzinger, PC, Fakih, MG, Fenton, MJ, Fuchs, CS, Grem, JL, Hunt, S, Kamel, A, Leong, LA, Lin, E, May, KS, Mulcahy, MF, Murphy, K, Rohren, E, Ryan, DP, Saltz, L, Sharma, S, Shibata, D, Skibber, JM, Jr, WS, Sofocleous, CT, Venook, AP, Willett, CG, Gregory, KM & Freedman-Cass, DA 2013, 'Metastatic colon cancer, version 3.2013: Featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 11, no. 2, pp. 141-152.
Benson, Al B. ; Bekaii-Saab, Tanios ; Chan, Emily ; Chen, Yi Jen ; Choti, Michael A. ; Cooper, Harry S. ; Engstrom, Paul F. ; Enzinger, Peter C. ; Fakih, Marwan G. ; Fenton, Moon J. ; Fuchs, Charles S. ; Grem, Jean L. ; Hunt, Steven ; Kamel, Ahmed ; Leong, Lucille A. ; Lin, Edward ; May, Kilian Salerno ; Mulcahy, Mary F. ; Murphy, Kate ; Rohren, Eric ; Ryan, David P. ; Saltz, Leonard ; Sharma, Sunil ; Shibata, David ; Skibber, John M. ; Jr, William Small ; Sofocleous, Constantinos T. ; Venook, Alan P. ; Willett, Christopher G. ; Gregory, Kristina M. ; Freedman-Cass, Deborah A. / Metastatic colon cancer, version 3.2013 : Featured updates to the NCCN guidelines. In: JNCCN Journal of the National Comprehensive Cancer Network. 2013 ; Vol. 11, No. 2. pp. 141-152.
@article{231930da0e5a44619f7aba73534903e9,
title = "Metastatic colon cancer, version 3.2013: Featured updates to the NCCN guidelines",
abstract = "The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, peri-operative treatment, patient surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Colon Cancer Panel meets annually to review comments from reviewers within their institutions and to reevaluate and update their recommendations. In addition, the panel has interim conferences as new data necessitate. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel's discussions surrounding metastatic colorectal cancer for the 2013 update of the guidelines. Importantly, changes were made to the continuum of care for patients with advanced or metastatic disease, including new drugs and an additional line of therapy.",
author = "Benson, {Al B.} and Tanios Bekaii-Saab and Emily Chan and Chen, {Yi Jen} and Choti, {Michael A.} and Cooper, {Harry S.} and Engstrom, {Paul F.} and Enzinger, {Peter C.} and Fakih, {Marwan G.} and Fenton, {Moon J.} and Fuchs, {Charles S.} and Grem, {Jean L.} and Steven Hunt and Ahmed Kamel and Leong, {Lucille A.} and Edward Lin and May, {Kilian Salerno} and Mulcahy, {Mary F.} and Kate Murphy and Eric Rohren and Ryan, {David P.} and Leonard Saltz and Sunil Sharma and David Shibata and Skibber, {John M.} and Jr, {William Small} and Sofocleous, {Constantinos T.} and Venook, {Alan P.} and Willett, {Christopher G.} and Gregory, {Kristina M.} and Freedman-Cass, {Deborah A.}",
year = "2013",
month = "2",
day = "1",
language = "English (US)",
volume = "11",
pages = "141--152",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "2",

}

TY - JOUR

T1 - Metastatic colon cancer, version 3.2013

T2 - Featured updates to the NCCN guidelines

AU - Benson, Al B.

AU - Bekaii-Saab, Tanios

AU - Chan, Emily

AU - Chen, Yi Jen

AU - Choti, Michael A.

AU - Cooper, Harry S.

AU - Engstrom, Paul F.

AU - Enzinger, Peter C.

AU - Fakih, Marwan G.

AU - Fenton, Moon J.

AU - Fuchs, Charles S.

AU - Grem, Jean L.

AU - Hunt, Steven

AU - Kamel, Ahmed

AU - Leong, Lucille A.

AU - Lin, Edward

AU - May, Kilian Salerno

AU - Mulcahy, Mary F.

AU - Murphy, Kate

AU - Rohren, Eric

AU - Ryan, David P.

AU - Saltz, Leonard

AU - Sharma, Sunil

AU - Shibata, David

AU - Skibber, John M.

AU - Jr, William Small

AU - Sofocleous, Constantinos T.

AU - Venook, Alan P.

AU - Willett, Christopher G.

AU - Gregory, Kristina M.

AU - Freedman-Cass, Deborah A.

PY - 2013/2/1

Y1 - 2013/2/1

N2 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, peri-operative treatment, patient surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Colon Cancer Panel meets annually to review comments from reviewers within their institutions and to reevaluate and update their recommendations. In addition, the panel has interim conferences as new data necessitate. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel's discussions surrounding metastatic colorectal cancer for the 2013 update of the guidelines. Importantly, changes were made to the continuum of care for patients with advanced or metastatic disease, including new drugs and an additional line of therapy.

AB - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, peri-operative treatment, patient surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Colon Cancer Panel meets annually to review comments from reviewers within their institutions and to reevaluate and update their recommendations. In addition, the panel has interim conferences as new data necessitate. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel's discussions surrounding metastatic colorectal cancer for the 2013 update of the guidelines. Importantly, changes were made to the continuum of care for patients with advanced or metastatic disease, including new drugs and an additional line of therapy.

UR - http://www.scopus.com/inward/record.url?scp=84874641687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874641687&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 141

EP - 152

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 2

ER -